Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Results 1 - 10 of 25
Results/page:
12 3 > 
Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial
ID: 733379
Start date: 2017-01-01, End date: 2021-12-31
Ischemic stroke (IS), caused by occlusion of arteries that supply blood to the brain, remains a leading cause of mortality and morbidity in the world. Disruption of blood and oxygen supply to the brain leads to neuronal death in the ischemic core within minutes. The...
Programme: H2020-EU.3.1.3.
Record Number: 207449
Last updated on: 2017-03-01
Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’:  A Randomized Controlled Multicentre Trial
ID: 733203
Start date: 2017-01-01, End date: 2021-12-31
Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time but continue to increase in diameter before they eventually rupture. Left untreated, the patients’ prognosis is dismal, since the internal bleeding...
Programme: H2020-EU.3.1.3.
Record Number: 207446
Last updated on: 2017-03-31
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
ID: 733008
Start date: 2017-01-01, End date: 2022-12-31
IMMUNOSABR is geared towards opening up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy. High precision stereotactic ablative radiotherapy (SABR) is combined with immunotherapy to form a...
Programme: H2020-EU.3.1.3.
Record Number: 207443
Last updated on: 2017-05-23
Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study
ID: 731532
Start date: 2017-01-01, End date: 2021-06-30
Chronic angina pectoris is a debilitating chronic disease, a subgroup of these patients suffers from refractory angina which unfortunately can’t be controlled by medical therapy (angioplasty or surgery). Refractory angina is a substantial burden on the individual and...
Programme: H2020-EU.3.1.3.
Record Number: 207197
Last updated on: 2017-05-23
Multisystem Cell Therapy for Improvement of Urinary Continence
ID: 731377
Start date: 2017-01-01, End date: 2021-12-31
"Stress Urinary Incontinence (SUI) is a disease affecting over 200 million people worldwide. It represents a condition with a prevalence of 20-50% in women, thereby creating an immense socio-economic burden. The currently available treatment strategies entail various...
Programme: H2020-EU.3.1.3.
Record Number: 207193
Last updated on: 2017-05-23
"Proposals should target regenerative medicine therapies which are ready for clinical (in-patient) research and should focus on one specific clinical phase of work. Any stage of clinical work (e.g., first in man, late stage trial, observational study) may be proposed though...
Record Number: 700804
"The objective is to establish a multinational and multidisciplinary consortium across Latin America and other affected or at risk regions, able to implement the urgently needed research during the ongoing ZIKV outbreak. The proposal should address all of the following issues:...
Record Number: 700786
"Proposals should focus on clinical trial(s), supporting proof of concept of clinical safety and efficacy in humans[[Phase 3 and phase 4 clinical trials are excluded.]] of novel therapies (pharmacological as well as non-pharmacological) or the optimisation of available...
Record Number: 700813
12 3 > 
List retrieved on: 2017-07-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top